United States · 
Who invested in Inflammatix?
Inflammatix's investors include Khosla Ventures, National Institutes of Health and Northpond Ventures.
United States · Series E startup
Who invested in Inflammatix
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$57Mraised across 1 round since 2024, from 1 source
- Latest round
- Series E, $57MSept 2024
- Investors
- 3
The rounds
- Sept 2024
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Inflammatix
How much has Inflammatix raised?
Inflammatix has raised $57M across 1 round since 2024.
When did Inflammatix last raise?
Inflammatix's most recent round was a Series E of $57M in Sept 2024.
What was Inflammatix's biggest round?
Its most recent round, $57M in Sept 2024, is also its largest on record.
Who backed Inflammatix first?
Inflammatix's first round on record, in Sept 2024, was backed by Khosla Ventures, National Institutes of Health and Northpond Ventures.
What stage is Inflammatix at?
Inflammatix's latest named round is a Series E, in Sept 2024.
Where is Inflammatix based?
Inflammatix is based in the United States.
Companies like Inflammatix
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.